Click for best price
Hospitalacquired Infection Diagnostics Market Size, Share 2022
This report contains market size and forecasts of Hospital-acquired Infection Diagnostics in Global, including the following market information:
- Global Hospital-acquired Infection Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hospital-acquired Infection Diagnostics market was valued at 4991.3 million in 2021 and is projected to reach US$ 7439.1 million by 2028, at a CAGR of 5.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Instrument and Reagents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hospital-acquired Infection Diagnostics include Abbott Laboratories, Advan DX, Abbott, Astrazeneca PLC, Bayer Schering Pharma LLC, Becton Dickinson And Company, Cepheid Inc., Roche AG and Daiichi Sankyo and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital-acquired Infection Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital-acquired Infection Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hospital-acquired Infection Diagnostics Market Segment Percentages, by Type, 2021 (%)
- Instrument and Reagents
- Consumables
Global Hospital-acquired Infection Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hospital-acquired Infection Diagnostics Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinics
- Ambulatory Surgery Centers (ASC)
- Others
Global Hospital-acquired Infection Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hospital-acquired Infection Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hospital-acquired Infection Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Hospital-acquired Infection Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Advan DX
- Abbott
- Astrazeneca PLC
- Bayer Schering Pharma LLC
- Becton Dickinson And Company
- Cepheid Inc.
- Roche AG
- Daiichi Sankyo
- Hologic, Inc.
| Report Attributes |
Report Details |
| Report Title |
Hospital-acquired Infection Diagnostics Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital-acquired Infection Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-acquired Infection Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital-acquired Infection Diagnostics Overall Market Size
2.1 Global Hospital-acquired Infection Diagnostics Market Size: 2021 VS 2028
2.2 Global Hospital-acquired Infection Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital-acquired Infection Diagnostics Players in Global Market
3.2 Top Global Hospital-acquired Infection Diagnostics Companies Ranked by Revenue
3.3 Global Hospital-acquired Infection Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Hospital-acquired Infection Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hospital-acquired Infection Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-acquired Infection Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Hospital-acquired Infection Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-acquired Infection Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hospital-acquired Infection Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Instrument and Reagents
4.1.3 Consumables
4.2 By Type - Global Hospital-acquired Infection Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Hospital-acquired Infection Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Hospital-acquired Infection Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital-acquired Infection Diagnostics Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Ambulatory Surgery Centers (ASC)
5.1.5 Others
5.2 By Application - Global Hospital-acquired Infection Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Hospital-acquired Infection Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Hospital-acquired Infection Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hospital-acquired Infection Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Hospital-acquired Infection Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Hospital-acquired Infection Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Hospital-acquired Infection Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hospital-acquired Infection Diagnostics Revenue, 2017-2028
6.3.2 US Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.3.3 Canada Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.3.4 Mexico Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hospital-acquired Infection Diagnostics Revenue, 2017-2028
6.4.2 Germany Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.4.3 France Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.4.4 U.K. Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.4.5 Italy Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.4.6 Russia Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.4.8 Benelux Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hospital-acquired Infection Diagnostics Revenue, 2017-2028
6.5.2 China Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.5.3 Japan Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.5.4 South Korea Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.5.6 India Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hospital-acquired Infection Diagnostics Revenue, 2017-2028
6.6.2 Brazil Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.6.3 Argentina Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-acquired Infection Diagnostics Revenue, 2017-2028
6.7.2 Turkey Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.7.3 Israel Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Hospital-acquired Infection Diagnostics Market Size, 2017-2028
6.7.5 UAE Hospital-acquired Infection Diagnostics Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Major Product Offerings
7.1.4 Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Advan DX
7.2.1 Advan DX Corporate Summary
7.2.2 Advan DX Business Overview
7.2.3 Advan DX Hospital-acquired Infection Diagnostics Major Product Offerings
7.2.4 Advan DX Hospital-acquired Infection Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Advan DX Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Hospital-acquired Infection Diagnostics Major Product Offerings
7.3.4 Abbott Hospital-acquired Infection Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Abbott Key News
7.4 Astrazeneca PLC
7.4.1 Astrazeneca PLC Corporate Summary
7.4.2 Astrazeneca PLC Business Overview
7.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Major Product Offerings
7.4.4 Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Astrazeneca PLC Key News
7.5 Bayer Schering Pharma LLC
7.5.1 Bayer Schering Pharma LLC Corporate Summary
7.5.2 Bayer Schering Pharma LLC Business Overview
7.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Major Product Offerings
7.5.4 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Bayer Schering Pharma LLC Key News
7.6 Becton Dickinson And Company
7.6.1 Becton Dickinson And Company Corporate Summary
7.6.2 Becton Dickinson And Company Business Overview
7.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Major Product Offerings
7.6.4 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue in Global Market (2017-2022)
7.6.5 Becton Dickinson And Company Key News
7.7 Cepheid Inc.
7.7.1 Cepheid Inc. Corporate Summary
7.7.2 Cepheid Inc. Business Overview
7.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Major Product Offerings
7.7.4 Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Cepheid Inc. Key News
7.8 Roche AG
7.8.1 Roche AG Corporate Summary
7.8.2 Roche AG Business Overview
7.8.3 Roche AG Hospital-acquired Infection Diagnostics Major Product Offerings
7.8.4 Roche AG Hospital-acquired Infection Diagnostics Revenue in Global Market (2017-2022)
7.8.5 Roche AG Key News
7.9 Daiichi Sankyo
7.9.1 Daiichi Sankyo Corporate Summary
7.9.2 Daiichi Sankyo Business Overview
7.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Major Product Offerings
7.9.4 Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue in Global Market (2017-2022)
7.9.5 Daiichi Sankyo Key News
7.10 Hologic, Inc.
7.10.1 Hologic, Inc. Corporate Summary
7.10.2 Hologic, Inc. Business Overview
7.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Major Product Offerings
7.10.4 Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue in Global Market (2017-2022)
7.10.5 Hologic, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital-acquired Infection Diagnostics Market Opportunities & Trends in Global Market
Table 2. Hospital-acquired Infection Diagnostics Market Drivers in Global Market
Table 3. Hospital-acquired Infection Diagnostics Market Restraints in Global Market
Table 4. Key Players of Hospital-acquired Infection Diagnostics in Global Market
Table 5. Top Hospital-acquired Infection Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hospital-acquired Infection Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hospital-acquired Infection Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hospital-acquired Infection Diagnostics Product Type
Table 9. List of Global Tier 1 Hospital-acquired Infection Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-acquired Infection Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hospital-acquired Infection Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hospital-acquired Infection Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hospital-acquired Infection Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hospital-acquired Infection Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hospital-acquired Infection Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hospital-acquired Infection Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Hospital-acquired Infection Diagnostics Product Offerings
Table 32. Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Advan DX Corporate Summary
Table 34. Advan DX Hospital-acquired Infection Diagnostics Product Offerings
Table 35. Advan DX Hospital-acquired Infection Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Hospital-acquired Infection Diagnostics Product Offerings
Table 38. Abbott Hospital-acquired Infection Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Astrazeneca PLC Corporate Summary
Table 40. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Offerings
Table 41. Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Bayer Schering Pharma LLC Corporate Summary
Table 43. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Offerings
Table 44. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Becton Dickinson And Company Corporate Summary
Table 46. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Offerings
Table 47. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Cepheid Inc. Corporate Summary
Table 49. Cepheid Inc. Hospital-acquired Infection Diagnostics Product Offerings
Table 50. Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Roche AG Corporate Summary
Table 52. Roche AG Hospital-acquired Infection Diagnostics Product Offerings
Table 53. Roche AG Hospital-acquired Infection Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Daiichi Sankyo Corporate Summary
Table 55. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Offerings
Table 56. Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. Hologic, Inc. Corporate Summary
Table 58. Hologic, Inc. Hospital-acquired Infection Diagnostics Product Offerings
Table 59. Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hospital-acquired Infection Diagnostics Segment by Type in 2021
Figure 2. Hospital-acquired Infection Diagnostics Segment by Application in 2021
Figure 3. Global Hospital-acquired Infection Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hospital-acquired Infection Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hospital-acquired Infection Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-acquired Infection Diagnostics Revenue in 2021
Figure 8. By Type - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hospital-acquired Infection Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Advan DX Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Roche AG Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
